Results 71 to 80 of about 92,715 (204)

Assessment of Environmental Contamination and Environmental Decontamination Practices within an Ebola Holding Unit, Freetown, Sierra Leone. [PDF]

PLoS ONE, 2015
Evidence to inform decontamination practices at Ebola holding units (EHUs) and treatment centres is lacking. We conducted an audit of decontamination procedures inside Connaught Hospital EHU in Freetown, Sierra Leone, by assessing environmental swab ...
Daniel Youkee, Colin S Brown, Paul Lilburn, Nandini Shetty, Tim Brooks, Andrew Simpson, Neil Bentley, Marta Lado, Thaim B Kamara, Naomi F Walker, Oliver Johnson   +10 more
doaj   +1 more source

The biogeographic basis of Ebola-virus disease outbreaks: A model for other zoonotic diseases? [PDF]

, 2017
We first determined the differential role of favorability of environmental conditions and mammalian chorotypes in explaining the presence of the Ebola virus in Africa.
Fa, John E., Farfán, Miguel Ángel, Márquez, Ana Luz, Nasi, Robert, Olivero, Jesús, Real, Raimundo, Vargas-Yañez, Juan Mario   +6 more
core  

Projections of epidemic transmission and estimation of vaccination impact during an ongoing Ebola virus disease outbreak in Northeastern Democratic Republic of Congo, as of Feb. 25, 2019. [PDF]

, 2019
BackgroundAs of February 25, 2019, 875 cases of Ebola virus disease (EVD) were reported in North Kivu and Ituri Provinces, Democratic Republic of Congo.
Hoff, Nicole A, Kelly, J Daniel, Lietman, Thomas M, Mossoko, Mathias, Musene, Kamy, Muyembe Tamfum, Jean Jacques, Okitolonda-Wemakoy, Emile, Porco, Travis C, Rimoin, Anne W, Rutherford, George W, Selo, Bernice, Wannier, Rae, Worden, Lee   +12 more
core   +1 more source

From Lake Victoria to the Tap: Antibiotic Resistance and Pathogenic Contamination of Kisumu City Water Supply and Wastewater Network

Tropical Medicine &International Health, EarlyView.
ABSTRACT Waterborne diseases and antimicrobial resistance (AMR) pose mounting public health threats across sub‐Saharan Africa, particularly in rapidly urbanising regions dependent on untreated or poorly treated surface waters. This study applied shotgun metagenomic sequencing to characterise microbial communities, virulence factors and antibiotic ...
Oleg N. Reva, Anthony Sifuna, Francis Orata, Caroline Omolo, Jacob Stanley Iramiot, Mark C. Enright, Awelani Mutshembele, Jian Zhou, William A. Shivoga   +8 more
wiley   +1 more source

The Social and Political Dimensions of the Ebola Response: Global Inequality, Climate Change, and Infectious Disease [PDF]

, 2016
The 2014 Ebola crisis has highlighted public-health vulnerabilities in Liberia, Sierra Leone, and Guinea – countries ravaged by extreme poverty, deforestation and mining-related disruption of livelihoods and ecosystems, and bloody civil wars in the ...
A Kay, A Mabin, A Petherick, AM Saéz, AR Poteete, AT Price-Smith, BA Israel, C Bayntun, D Healy, DA Oladele, E Goffman, E Roe, G Bankoff, G Mitman, GB Cockerham, H Frumkin, I Rashid, J Chippaux, J Moran-Ellis, JC Cohen, JC Dumont, JD Mayer, JE Pinzon, K Lee, KC Seto, M Karamouzian, M Nichter, N Brenner, NL Klenk, P Wald, R Bloch, R Bloch, R Keil, R Keil, R Shields, RE Kasperson, S Baize, S Harman, S Lewis, SH Ali, SM Teutsch, T Olaniyan   +41 more
core   +1 more source

Aosta Valley animal cancer registry: A collaborative initiative for monitoring cancer burden in animals

Veterinary Record Open, Volume 13, Issue 1, June 2026.
Abstract Background Animal cancer registry data are important for monitoring animal health, for prevention and research in veterinary medicine, and for comparative oncology. Since people and animals share the same environment and are exposed to many common risk factors, cancer patterns in animals may have a sentinel function for human health.
Claudio Trentin, Giulio Barigelletti, Caterina Abate, Giovanna Michela Villa, Emilio Bazzocchi, Lorenzo Domenis, Silvia Vuillermoz, Magda Giulia Santini, Barbara Avuzzi, Alessandro Borgini, Giovanna Tagliabue   +10 more
wiley   +1 more source

Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): Ebola virus disease

EFSA Journal, 2017
Ebola virus disease has been assessed according to the criteria of the Animal Health Law (AHL), in particular criteria of Article 7 on disease profile and impacts, Article 5 on the eligibility of Ebola virus disease to be listed, Article 9 for the ...
EFSA Panel on Animal Health and Welfare (AHAW), Simon More, Anette Bøtner, Andrew Butterworth, Paolo Calistri, Klaus Depner, Sandra Edwards, Bruno Garin‐Bastuji, Margaret Good, Christian Gortázar Schmidt, Virginie Michel, Miguel Angel Miranda, Søren Saxmose Nielsen, Mohan Raj, Liisa Sihvonen, Hans Spoolder, Jan Arend Stegeman, Hans‐Hermann Thulke, Antonio Velarde, Preben Willeberg, Christoph Winckler, Francesca Baldinelli, Alessandro Broglia, Beatriz Beltrán Beck, Lisa Kohnle, Joana Morgado, Dominique Bicout   +26 more
doaj   +1 more source

What do we really fear? The epidemiological characteristics of Ebola and our preparedness [PDF]

Epidemiology and Health, 2014
Ebola virus disease (hereafter Ebola) has a high fatality rate; currently lacks a treatment or vaccine with proven safety and efficacy, and thus many people fear this infection.
Moran Ki
doaj   +1 more source

Ebola Virus Diseases

African Journal of Clinical and Experimental Microbiology, 2014
Since the first reported outbreak of Ebola in 1976, there have been approximately 25 outbreaks all of which, except two, have been reported only in east and central Africa. The current outbreak and a single case reported in 1994 in Ivory Coast are the only two outbreaks in West Africa (7).
Elisha, A, Adegboro, B
openaire   +3 more sources

Lab‐Scale Continuous Biomanufacturing: A Tool for Process Development With Adaptive Strategies for Capture and Virus Inactivation

Biotechnology and Bioengineering, Volume 123, Issue 4, Page 924-938, April 2026.
Schematic representation of the continuous lab‐scale process. ABSTRACT Monoclonal antibodies (mAbs) are nowadays fundamental in treating a wide range of severe diseases, including cancer, infections, or autoimmune disorders. Due to their high specificity, potent activity, and fewer side effects compared to small molecular drugs, the market for mAbs is ...
Thomas Kruse, Fabian Schmitz, Janina Kilian, Jonas Austerjost, Lucas‐Nik Reger, Markus Kampmann   +5 more
wiley   +1 more source